Trial Profile
Double-Blind Randomised Investigation of Tibolone Alone or in Adjunct to Standard Antidepressant Treatment for Depression in Menopausal Women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jan 2020
Price :
$35
*
At a glance
- Drugs Tibolone (Primary)
- Indications Depressive disorders; Menopausal syndrome
- Focus Therapeutic Use
- 06 Jan 2020 Status changed from recruiting to completed.
- 07 Aug 2017 Planned End Date changed from 1 Jan 2017 to 1 Dec 2019.
- 07 Aug 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Dec 2019.